Company intelligence / Profile preview

Diascopic

Columbus, Ohio, United States

Ownership: Private
Development stage: Commercial

Overview

Diascopic has developed a portable digital diagnostic system capable of detecting pathogens within seconds. The system uses a unique three-step target verification process to provide high-throughput and accurate results for disease diagnosis at the point of care. It has been specifically highlighted for its application in rapid tuberculosis detection[1].

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Diascopic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diascopic.

Explore the full profile